NO942919L - Fenylalaninanaloger av bombesin - Google Patents

Fenylalaninanaloger av bombesin

Info

Publication number
NO942919L
NO942919L NO942919A NO942919A NO942919L NO 942919 L NO942919 L NO 942919L NO 942919 A NO942919 A NO 942919A NO 942919 A NO942919 A NO 942919A NO 942919 L NO942919 L NO 942919L
Authority
NO
Norway
Prior art keywords
bombesin
derivatives
phenylalanine analogues
tests
antagonizing
Prior art date
Application number
NO942919A
Other languages
English (en)
Other versions
NO942919D0 (no
Inventor
Judson Vincent Edwards
Bradford Otto Fanger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO942919L publication Critical patent/NO942919L/no
Publication of NO942919D0 publication Critical patent/NO942919D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Beskrevet er agonister og antagonister av bombesin som er deri- vater av naturlig forekommende bombesin som utviser modifiserte derivater av i fenylalanin. Agonist- og antagonist- ; aktiviteter ble bekreftet under an- vendelse av konvensjonelle, konkurrer- ende bindings- og biokjemiske utprøv- ninger, så vel som konvensjonelle, fysiologiske tester, og anvendelse av disse derivater i et utall tilstander. Anvendelse av disse peptider kan være anvendbare for stimulering eller anta- gonisering av vekst av vev, spesielt lungevev, og av fordøyelse. Behandling omfatter administrering til en pasient med behov for det, av en effektiv mengde av en bombesinanalog.
NO942919A 1992-02-07 1994-08-05 Fenylalaninanaloger av bombesin NO942919L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83383492A 1992-02-07 1992-02-07
PCT/US1993/000183 WO1993016105A1 (en) 1992-02-07 1993-01-07 Phenylalanine analogs of bombesin

Publications (2)

Publication Number Publication Date
NO942919L true NO942919L (no) 1994-08-05
NO942919D0 NO942919D0 (no) 1994-08-05

Family

ID=25265391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942919A NO942919L (no) 1992-02-07 1994-08-05 Fenylalaninanaloger av bombesin

Country Status (14)

Country Link
US (1) US5428018A (no)
EP (1) EP0626973A1 (no)
JP (1) JPH07505865A (no)
KR (1) KR950700325A (no)
AU (1) AU668909B2 (no)
CA (1) CA2129032A1 (no)
FI (1) FI943638A0 (no)
HU (1) HUT71585A (no)
IL (1) IL104621A0 (no)
MX (1) MX9300602A (no)
NO (1) NO942919L (no)
NZ (1) NZ246815A (no)
WO (1) WO1993016105A1 (no)
ZA (1) ZA93716B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US7078413B2 (en) 1996-04-19 2006-07-18 Wisconsin Alumni Research Foundation Compositions and methods of use for a bombesin peptide
UA65549C2 (uk) 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
CA2283854A1 (en) * 1997-04-22 1998-10-29 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
CA2512310C (en) * 2003-01-13 2012-09-25 Bracco Imaging S.P.A. Improved linkers for radiopharmaceutical compounds
PL2900279T3 (pl) 2012-09-25 2020-05-18 Advanced Accelerator Applications Usa, Inc. Antagonisty grpr do wykrywania, diagnostyki i leczenia raka grpr-pozytywnego

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
US4631270A (en) * 1978-11-20 1986-12-23 Research Corporation Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
ATE16495T1 (de) * 1981-06-22 1985-11-15 Ici Plc Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
EP0313158A3 (en) * 1987-10-23 1990-08-22 Merck & Co. Inc. Gastrin releasing peptide antagonist
US5047502A (en) * 1987-10-23 1991-09-10 Merck And Co., Inc. Gastrin releasing peptide antagonist
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8806644D0 (en) * 1988-03-21 1988-04-20 Imp Cancer Res Tech Neuropeptide antagonists
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
DE68928667T2 (de) * 1988-10-14 1998-10-01 Univ Tulane Peptide als arzneimittel
US5028692A (en) * 1989-04-25 1991-07-02 Merck & Co., Inc. Gastrin releasing peptide antagonist
IL96216A0 (en) * 1989-11-06 1991-08-16 Erba Carlo Spa Peptide derivatives,their preparation and pharmaceutical compositions containing them
NZ236114A (en) * 1989-11-22 1993-04-28 Merrell Dow Pharma Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions
EP0531342A1 (en) * 1990-05-09 1993-03-17 The Administrators Of The Tulane Educational Fund Cyclized and linear therapeutic peptides
ZA915740B (en) * 1990-07-26 1992-05-27 Merrell Dow Pharma Peptides
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists

Also Published As

Publication number Publication date
MX9300602A (es) 1993-08-01
CA2129032A1 (en) 1993-08-19
FI943638L (fi) 1994-08-05
JPH07505865A (ja) 1995-06-29
WO1993016105A1 (en) 1993-08-19
IL104621A0 (en) 1993-06-10
FI943638A7 (fi) 1994-08-05
HUT71585A (en) 1995-12-28
US5428018A (en) 1995-06-27
FI943638A0 (fi) 1994-08-05
HU9402285D0 (en) 1994-10-28
NZ246815A (en) 1996-02-27
ZA93716B (en) 1993-09-01
EP0626973A1 (en) 1994-12-07
NO942919D0 (no) 1994-08-05
AU668909B2 (en) 1996-05-23
KR950700325A (ko) 1995-01-16
AU3439993A (en) 1993-09-03

Similar Documents

Publication Publication Date Title
NO942919L (no) Fenylalaninanaloger av bombesin
Konishi et al. The effects of substance P and other peptides on spinal neurons of the frog
Solomon et al. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33
Ferland et al. Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence
DE69630133T2 (de) Analoga des parathyroid-hormons
ATE156492T1 (de) Bombesinanaloge
Cholewinski et al. Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide
US5717062A (en) Cyclic analogs of PTH and PTHrP
DE69725850T2 (de) Analoge des parathormons zur behandlung der osteoporose
NO20051804L (no) GHRH analoger
SE8802569D0 (sv) Improvements in or relation to somatostatins
Ishibashi et al. Inhibition of growth of human small cell lung cancer by bromocriptine
Mizrahi et al. Substance P antagonists active in vitro and in vivo
Vigna et al. Effects of cholecystokinin, gastrin, and related peptides on coho salmon gallbladder contraction in vitro.
Potter et al. [Pro34] neuropeptide Y selectively identifies postjunctional-mediated actions of neuropeptide Y in vivo in rats and dogs
NO941151L (no) Lineære adhesjonsinhibitorer
Löffler et al. Parathyrin and calcitonin stimulate cyclic AMP accumulation in cultured murine brain cells.
Muneoka et al. Pharmacology of FMRFamide in Mytilus catch muscle
Huang et al. Parathyroid hormone stimulates adenylate cyclase in rat cerebral microvessels
Liang et al. Substance P stimulation of amylase release by isolated parotid cells and inhibition of substance P induction of salivation by vasoactive peptides
Vigna Evolution of endocrine regulation of gastrointestinal function in lower vertebrates
ES2084635T3 (es) Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina.
Regoli et al. Neurokinin A. A pharmacological study
McGeachie et al. Reaction of skeletal muscle to small implants of titanium or stainless steel: a quantitative histological and autoradiographic study
Stewart et al. Bradykinin antagonists as new drugs for prostate cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application